Document Detail


Increased maternal serum and cord blood fibronectin concentrations in preeclampsia are associated with higher placental hyaluronic acid and hydroxyproline content.
MedLine Citation:
PMID:  20367505     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Total or cellular fibronectin (FN) determinations have been used to differentiate between normal and preeclamptic pregnants. The purpose of this study was to examine the relationship between maternal serum FN levels and the extracellular matrix molecule contents of placental tissue, such as FN, hyaluronic acid (HA) and hydroxyproline (HP) levels. MATERIAL AND METHODS: We obtained maternal blood samples and placental tissue samples from healthy (n = 17, controls) and preeclamptic pregnants (n = 29). We also obtained cord blood samples for FN and HA determination from the same patients. FN and HA concentrations in the placenta and maternal and cord blood were measured by and enzyme-linked immunosorbent assay and HP contents in the placenta were measured by a colorimetric assay. RESULTS: FN levels in maternal serum, cord blood, and placenta were significantly higher in preeclamptics than in controls (p<0.001, p<0.001 and p<0.05, respectively). HA concentrations in the cord blood and placenta were found to be elevated in preeclamptics (p<0.05 and p<0.01). Preeclamptics had significantly higher placental HP levels than controls (p<0.001). Similar statistically significant results were obtained when the pregnant subjects classified as nulliparous and multiparous. There was no difference in ECM molecule levels between nulliporous and multiparous women in preeclamptic pregnant group. In regression analysis maternal serum FN levels were correlated with placental HA and HP levels (p<0.01 and p<0.01). There was a positive correlation between cord blood FN and both placental HP (p<001) and HA levels (p<0.01). FN levels in maternal serum, cord blood, and placenta were also negative correlated with fetal birth weight (p<0.01, p<0.05 and p<0.05, respectively). CONCLUSION: FN in maternal serum, cord blood, and placenta is increased with elevated placental HA and HP levels, probably reflecting placental basement membrane alterations during preeclampsia.
Authors:
Hafize Uzun; Dildar Konukoglu; Mustafa Albayrak; Ali Benian; Riza Madazli; Seval Aydin; Remisa Gelisgen; S Uludag
Related Documents :
2443385 - Characterization of lymphocyte subpopulations in human cord blood using the immunogold ...
6327765 - Cellular defenses against toxoplasma gondii in newborns.
6505835 - Effects of a contusion injury on spinal cord blood flow in the sheep.
11882335 - Unique character and metabolism of high density lipoprotein (hdl) in fetus.
9158895 - Effect of the method of killing, interval between killing and neck cutting and blood ve...
1151745 - A study of absorption of compounds from the rat biliary tree by retrograde intrabiliary...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hypertension in pregnancy : official journal of the International Society for the Study of Hypertension in Pregnancy     Volume:  29     ISSN:  1525-6065     ISO Abbreviation:  Hypertens Pregnancy     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-04-06     Completed Date:  2010-06-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421297     Medline TA:  Hypertens Pregnancy     Country:  England    
Other Details:
Languages:  eng     Pagination:  153-62     Citation Subset:  IM    
Affiliation:
Istanbul University, Cerrahpa?a Medical Faculty, Department of Biochemistry, Istanbul, Turkey. huzun59@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Case-Control Studies
Extracellular Matrix / metabolism
Female
Fetal Blood / metabolism
Fibronectins / blood*
Humans
Hyaluronic Acid / metabolism*
Hydroxyproline / metabolism*
Placenta / metabolism*
Pre-Eclampsia / blood*
Pregnancy
Young Adult
Chemical
Reg. No./Substance:
0/Fibronectins; 51-35-4/Hydroxyproline; 9004-61-9/Hyaluronic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections.
Next Document:  Predictive value of clinical and laboratory indices at first assessment in women referred with suspe...